This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in targeted therapies for cancer, immunological and inflammatory diseases. The research also covers technological developments across vaccines, neuroprotective medicines, cell therapies, monoclonal antibody and oncolytic virus platforms.



The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.



The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.



Keywords: Precision Medicine, Immunological Diseases, Stem Cells, iPSC, Neurological Diseases, Neuroprotective Therapies, Vaccines, Respiratory Diseases, Monoclonal Antibody, Inflammatory Diseases, Regenerative Macrophage Therapy, TCR-T Therapy, Cancer, Oncolytic HSV-1, Intrahepatic Cholangiocarcinoma, Targeted T-cell Antigen Coupler, Solid Cancer, Machine Learning, Drug Discovery